Follow The Filings

PCOR Procore Technologies Inc.

Information Technology, filed as PROCORE TECHNOLOGIES INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 3 managers in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $62M
  • 3 exits 1 small

In 2026 Q2 Chris James, Dennis Hong, and Chase Coleman sold out of Procore Technologies.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Add 0.09%

Who owns PCOR

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.09% Small add +2.0% 1,529,188 $62M History
Chris James, Meritage Group exited 2026 Q2 Last 2026 Q1 5.8% Exit −5.76% 2,678,410 $153M History
Chase Coleman, Tiger Global Management exited 2026 Q2 Last 2026 Q1 0.58% Exit −0.58% 2,339,500 $133M History
Dennis Hong, Shawspring Partners exited 2026 Q2 Last 2026 Q1 4.6% Exit −4.62% 216,756 $12M History

1 current, 3 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PCOR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PCOR insider trades
  • None no insider bought on the open market
  • $45.6M sold by 5 insiders outside a trading plan
  • $36.8M sold by 5 insiders under 10b5-1 plans
  1. Craig F. Courtemanche Jr. Chair
    Planned sale
    $3.2M 56,122 shares at $56.19 5.8% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  2. Connor Kevin J O Director
    Planned sale
    $831K 15,384 shares at $54.01 1.7% of stake
    Traded Oct 5–6 Filed Oct 7
    ↗
  3. Craig F. Courtemanche Jr. Chair
    Planned sale
    $3M 56,122 shares at $53.48 5.8% of stake
    Traded Sep 10 Filed Sep 14
    ↗
  4. Connor Kevin J O Director
    Planned sale
    $938K 15,384 shares at $60.99 1.6% of stake
    Traded Sep 1–2 Filed Sep 3
    ↗
  5. Benjamin C Singer Chief Legal Officer; Secretary
    Planned sale
    $250K 3,943 shares at $63.35 4.3% of stake
    Traded Aug 21 Filed Aug 24
    ↗
  6. Elisa Steele Director
    Planned sale
    $95K 1,500 shares at $63.00 2.5% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  7. William Fred Fleming Jr. SVP, Corporate Controller
    Sale
    $590K 10,000 shares at $58.95 8.7% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  8. Craig F. Courtemanche Jr. Chair
    Planned sale
    $3.2M 56,122 shares at $57.11 5.8% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  9. Connor Kevin J O Director
    Planned sale
    $1.3M 23,078 shares at $54.94 2.4% of stake
    Traded Aug 3–4 Filed Aug 5
    ↗
  10. Craig F. Courtemanche Jr. Chair
    Planned sale
    $2.5M 56,122 shares at $43.90 5.8% of stake
    Traded Jul 10 Filed Jul 14
    ↗
  11. Connor Kevin J O Director
    Planned sale
    $489K 11,538 shares at $42.37 1.2% of stake
    Traded Jul 1–2 Filed Jul 2
    ↗
  12. Connor Kevin J O Director
    Planned sale
    $490K 11,544 shares at $42.46 1.2% of stake
    Traded Jun 15–16 Filed Jun 17
    ↗
  13. Craig F. Courtemanche Jr. Chair
    Planned sale
    $2.5M 56,122 shares at $45.14 5.8% of stake
    Traded Jun 10 Filed Jun 12
    ↗
  14. Benjamin C Singer Chief Legal Officer; Secretary
    Planned sale
    $197K 3,942 shares at $50.00 3.9% of stake
    Traded May 29 Filed Jun 2
    ↗
  15. Craig F. Courtemanche Jr. Chair
    Planned sale
    $2.9M 56,122 shares at $51.06 5.7% of stake
    Traded May 11 Filed May 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 other transactions, 22 share withholdings for taxes, 20 stock grants, 16 option exercises, and 1 gift.

Congress

No member of Congress reported trading PCOR in the last three years. 2 members listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.95B $1.15B $1.32B
Gross profit $0.776B $0.946B $1.05B
Gross margin * 81.6% 82.1% 79.5%
Net income -$189.69M -$105.96M -$100.78M
Net margin * -20.0% -9.2% -7.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.956B $1.1B $1.17B
Total non-current assets * $0.938B $1B $1.07B
Total assets $1.89B $2.1B $2.24B
Total current liabilities $642.43M $728.03M $884.56M
Total non-current liabilities * $95.53M $84.99M $92.25M
Total equity $1.16B $1.29B $1.26B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $92.02M $196.17M $300.27M
Cash from investing -$76.06M -$150.11M -$70.5M
Cash from financing $41.16M $36.24M -$178.9M
Net change in cash * $57.12M $82.3M $50.87M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.